5‑Fluorouracil attenuates dextran sodium sulfate‑induced acute colitis in mice

Xiao,Junhua; Lu,Zhanjun; Sheng,Jiaqing; Song,Yunna; Jiang,Weiliang; Liu,Fei; Zheng,Ping

doi:10.3892/mmr.2016.4858

5‑Fluorouracil attenuates dextran sodium sulfate‑induced acute colitis in mice

Authors:
- Junhua Xiao
- Zhanjun Lu
- Jiaqing Sheng
- Yunna Song
- Weiliang Jiang
- Fei Liu
- Ping Zheng
View Affiliations

Affiliations: Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200092, P.R. China, Department of Gastroenterology, The First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, P.R. China, Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Published online on: February 3, 2016 https://doi.org/10.3892/mmr.2016.4858
Pages: 2821-2828

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

5‑Fluorouracil (5‑FU) has been predominantly used in the clinic for cancer chemotherapy. Previous studies have demonstrated that 5‑FU has an anti‑inflammatory function. In the current study, the potential therapeutic role of 5‑FU in dextran sodium sulfate (DSS)‑induced acute mouse colitis was investigated. Effects on the severity of colitis were studied via histochemical and immunohistochemical staining, cytokine levels were determined by reverse transcriptoin‑quantitative polymerase chain reaction and the effect of 5‑FU on NF‑κB was examined by western blotting. Administration of 5‑FU ameliorated the severity of acute DSS‑induced colitis. The disease activity score was significantly lower in the 5‑FU + DSS‑treated mice compared with the DSS‑treated group (P<0.01). Tumor necrosis factor‑α, interleukin‑1β and interferon γ mRNA expression levels were significantly downregulated in the colon tissue of DSS mice treated with 5‑FU compared with the untreated DSS mice (P<0.05). In addition, the number of CD4+ T cells in the colonic lamina propria and myeloperoxidase activity were significantly decreased in the 5‑FU + DSS‑treated mice (P<0.05). Furthermore, 5‑FU treatment significantly reduced p‑NF‑κB‑p56 protein expression levels in the colon tissue of DSS‑treated mice (P<0.05). The present results demonstrated that 5‑FU minimizes the abnormal immune cytokine response and relieves the pathophysiological disorders associated with experimental acute colitis. Thus, the modulating inflammatory response role of 5‑FU may be partially associated with inhibiting NF‑κB activation and 5‑FU may be a novel therapeutic strategy for the treatment of inflammatory bowel disease.

View Figures

View References

1	Xavier RJ and Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature. 448:427–434. 2007. View Article : Google Scholar : PubMed/NCBI
2	Ordás I, Eckmann L, Talamini M, Baumgart DC and Sandborn WJ: Ulcerative colitis. Lancet. 380:1606–1619. 2012. View Article : Google Scholar : PubMed/NCBI
3	Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW and Kaplan GG: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 142:46–54. 2012. View Article : Google Scholar
4	Grivennikov SI: Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 35:229–244. 2013. View Article : Google Scholar
5	Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M and Moum B: Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: Psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 11:909–918. 2005. View Article : Google Scholar
6	Harpaz N and Talbot IC: Colorectal cancer in idiopathic inflammatory bowel disease. Semin Diagn Pathol. 13:339–357. 1996.
7	Sandborn WJ: Azathioprine: State of the art in inflammatory bowel disease. Scand J Gastroenterol Suppl. 225:92–99. 1998. View Article : Google Scholar
8	Targownik LE and Bernstein CN: Infectious and malignant complications of TNF inhibitor therapy in IBD. Am J Gastroenterol. 108:1835–1842; quiz 1843. 2013. View Article : Google Scholar
9	Álvarez P, Marchal JA, Boulaiz H, Carrillo E, Vélez C, Rodríguez-Serrano F, Melguizo C, Prados J, Madeddu R and Aranega A: 5-Fluorouracil derivatives: A patent review. Expert Opin Ther Patents. 22:107–123. 2012. View Article : Google Scholar
10	Bielecki K, Wiedmann M, Meyer F, Kimura W and Mössner J: Effect of 5-fluorouracil on secretion and synthesis of pancreatic digestive enzymes: Studies in isolated pancreatic acini and perfused pancreas derived from normal rats and from rats with acute necrotizing pancreatitis. Pancreas. 9:518–525. 1994. View Article : Google Scholar
11	Rich TA, Shepard RC and Mosley ST: Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol. 22:2214–2232. 2004. View Article : Google Scholar
12	Chen X-L, Ciren S-Z, Zhang H, Duan LG and Wesley AJ: Effect of 5-FU on modulation of disarrangement of immune-associated cytokines in experimental acute pancreatitis. World J Gastroenterol. 15:2032–2037. 2009. View Article : Google Scholar :
13	Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV, et al: Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut. 60:1479–1486. 2011. View Article : Google Scholar
14	Song JL, Qian Y, Li GJ and Zhao X: Anti-inflammatory effects of kudingcha methanol extract (Ilex kudingcha C.J. Tseng) in dextran sulfate sodium-induced ulcerative colitis. Mol Med Rep. 8:1256–1262. 2013.PubMed/NCBI
15	Obermeier F, Dunger N, Strauch UG, Hofmann C, Bleich A, Grunwald N, Hedrich HJ, Aschenbrenner E, Schlegelberger B, Rogler G, et al: CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology. 129:913–27. 2005. View Article : Google Scholar
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
17	Bradley PP, Priebat DA, Christensen RD and Rothstein G: Cellular and extracellular myeloperoxidase in pyogenic inflammation. J Invest Dermatol. 78:206–209. 1982. View Article : Google Scholar : PubMed/NCBI
18	Berndt BE, Zhang M, Chen GH, Huffnagle GB and Kao JY: The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol. 179:6255–6262. 2007. View Article : Google Scholar
19	Kitajima S, Takuma S and Morimoto M: Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 48:137–143. 1999. View Article : Google Scholar : PubMed/NCBI
20	Li L, Ren F, Yun Z, An Y, Wang C and Yan X: Determination of the effects of lactoferrin in a preclinical mouse model of experimental colitis. Mol Med Rep. 8:1125–1129. 2013.
21	Karrasch T and Jobin C: NF-kappaB and the intestine: Friend or foe? Inflamm Bowel Dis. 14:114–124. 2008. View Article : Google Scholar
22	Schreiber S, Nikolaus S and Hampe J: Activation of nuclear factor kappa B inflammatory bowel disease. Gut. 42:477–484. 1998. View Article : Google Scholar : PubMed/NCBI
23	Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Schölmerich J and Gross V: Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology. 115:357–369. 1998. View Article : Google Scholar : PubMed/NCBI
24	Berndt U, Bartsch S, Philipsen L, Danese S, Wiedenmann B, Dignass AU, Hämmerle M and Sturm A: Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J Immunol. 179:295–304. 2007. View Article : Google Scholar
25	Pizarro TT and Cominelli F: Cytokine therapy for Crohn's disease: Advances in translational research. Annu Rev Med. 58:433–444. 2007. View Article : Google Scholar
26	Islam S, Hassan F, Tumurkhuu G, Ito H, Koide N, Mori I, Yoshida T and Yokochi T: 5-Fluorouracil prevents lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-kappaB activation. Cancer Chemother Pharmacol. 59:227–233. 2007. View Article : Google Scholar
27	Melen-Mucha G, Balcerczak E, Mucha S, Panczyk M, Lipa S and Mirowski M: Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation. Neoplasma. 51:319–324. 2004.PubMed/NCBI
28	Zhou MT, Chen BC and Sun HW: Continuous regional arterial infusion with fluorouracil and octreotide attenuates severe acute pancreatitis in a canine model. PLoS One. 7:e373472012. View Article : Google Scholar : PubMed/NCBI
29	Fournier BM and Parkos CA: The role of neutrophils during intestinal inflammation. Mucosal Immunol. 5:354–366. 2012. View Article : Google Scholar : PubMed/NCBI
30	Aarvak T and Natvig JB: Cell-cell interactions in synovitis: Antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res. 3:13–17. 2001. View Article : Google Scholar : PubMed/NCBI
31	Hayden MS, West AP and Ghosh S: NF-kappaB and the immune response. Oncogene. 25:6758–6780. 2006. View Article : Google Scholar : PubMed/NCBI
32	Keefe DM, Gibson RJ and Hauer-Jensen M: Gastrointestinal mucositis. Semin Oncol Nurs. 20:38–47. 2004. View Article : Google Scholar : PubMed/NCBI
33	Azevedo OG, Oliveira RA, Oliveira BC, Zaja-Milatovic S, Araújo CV, Wong DV, Costa TB, Lucena HB, Lima RC Jr, Ribeiro RA, et al: Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis. BMC Gastroenterol. 12:352012. View Article : Google Scholar : PubMed/NCBI
34	Saegusa Y, Ichikawa T, Iwai T, Goso Y, Okayasu I, Ikezawa T, Shikama N, Saigenji K and Ishihara K: Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol. 43:59–65. 2008. View Article : Google Scholar : PubMed/NCBI
35	Pritchard DM, Potten CS and Hickman JA: The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res. 58:5453–5465. 1998.PubMed/NCBI
36	Sakai H, Sagara A, Matsumoto K, Hasegawa S, Sato K, Nishizaki M, Shoji T, Horie S, Nakagawa T, Tokuyama S and Narita M: 5-Fluorouracil induces diarrhea with changes in the expression of inflammatory cytokines and aquaporins in mouse intestines. PLoS One. 8:e547882013. View Article : Google Scholar : PubMed/NCBI